| | UAE | eGFR |
|---|
β (95% CI) | p values | β (95% CI) | p values |
|---|
CIMT |
Model 1 | 0.10 (0.06–0.14) |  < 0.001 | − 0.23 (-0.27∽-0.20) |  < 0.001 |
Model 2 | 0.07 (0.04–0.11) |  < 0.001 | − 0.02 (-0.06–0.03) | 0.461 |
Model 3 | 0.07 (0.03–0.10) |  < 0.001 | − 0.01 (-0.05–0.03) | 0.486 |
Model 4 | 0.05 (0.02–0.09) | 0.006 | − 0.01 (-0.05–0.03) | 0.660 |
Model 5 | 0.05 (0.01–0.09) | 0.029 | − 0.01 (-0.05–0.04) | 0.701 |
FIMT |
Model 1 | 0.10 (0.06–0.14) |  < 0.001 | − 0.27 (-0.31∽-0.23) |  < 0.001 |
Model 2 | 0.08 (0.04–0.11) |  < 0.001 | − 0.04 (-0.08–0.00) | 0.053 |
Model 3 | 0.07 (0.04–0.11) |  < 0.001 | − 0.04 (-0.08–0.00) | 0.052 |
Model 4 | 0.08 (0.04–0.12) |  < 0.001 | − 0.04 (-0.08–0.00) | 0.070 |
Model 5 | 0.07 (0.03–0.11) | 0.001 | − 0.04 (-0.08–0.01) | 0.134 |
- UAE urinary albumin excretion, eGFR estimated glomerular filtration rate, DD duration of diabetes, APA anti-platelet agents, LLD lipid-lowering drugs, AHA anti-hypertensive agents, SBP systolic blood pressure, DBP diastolic blood pressure, WC waist circumference, WHR waist-to-hip ratio, BMI body mass index, FPG fasting plasma glucose, 2-h PPG 2-h postprandial plasma glucose, HbA1c glycated hemoglobin A1c, FCP fasting C-peptide, 2-h PCP 2-h postprandial C-peptide, HOMA2-IR HOMA of insulin resistance, TG total triglycerides, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, ALT alanine transaminase, SUA serum uric acid
- Model 1: unadjusted
- Model 2: Adjusted for age, sex, DD, hypertension, smoking status and alcohol use
- Model 3: Further adjustment for use of AHA, LLD, APA
- Model 4: Further adjustment for SBP, DBP, BMI, WC and WHR
- Model 5: Further adjustment for ALT, TG, TC, HDL-C, LDL-C, SUA, FPG, 2-h PPG, HbA1c, FCP, 2-h PCP, HOMA2-IR
